| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198779 Antiinflammatory agents; adult respiratory distress syndrome |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/07/2004 | US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine. |
| 10/07/2004 | US20040197390 Mixture of expression vector for antihemophilic factor and lipid; delivering of DNA expression vehicle encoding Factor VIII to a cell |
| 10/07/2004 | CA2519901A1 Bioreductively-activated prodrugs |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463707A2 A group of novel anti-cancer compounds with specific structure |
| 10/06/2004 | EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 10/06/2004 | EP1463501A1 Cis-imidazolines as mdm2 inhibitors |
| 10/06/2004 | EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
| 10/06/2004 | EP1169312B1 Glucokinase activators |
| 10/06/2004 | EP1154993B1 Thioamide derivatives |
| 10/06/2004 | EP0840608B1 Orotate salts of 5-amino or substituted amino 1,2,3-triazoles for treatment of neoplasms |
| 10/06/2004 | EP0808309B1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors |
| 10/06/2004 | CN1535486A Novel onium salt, electrolyte for nonaqueous cell containing novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 10/06/2004 | CN1535267A 5-membered heterocycles, preparation and use thereof as medicine |
| 10/06/2004 | CN1535148A Imidazole derivatives for moudlating sodium channels |
| 10/06/2004 | CN1534023A Heterocyclic compound as dopamine-D3ligand |
| 10/06/2004 | CN1534013A Preparation method of water soluble curcumin composition salt |
| 10/06/2004 | CN1169808C 'Beta'-carboline compound |
| 10/05/2004 | US6800778 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 10/05/2004 | CA2156024C Synthetic excitatory amino acids |
| 10/05/2004 | CA2103837C Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 10/05/2004 | CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 09/30/2004 | WO2004083487A1 Novel imidazole compound and usage thereof |
| 09/30/2004 | WO2004083187A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004083186A1 Therapeutic agent for viral hepatitis and carcinostatic agent |
| 09/30/2004 | WO2004083185A2 Phenyl substituted imidazole derivatives |
| 09/30/2004 | WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 09/30/2004 | WO2004083170A2 Compounds, a process for their preparation and their use as dyes and pigments |
| 09/30/2004 | WO2004082605A2 Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004082585A2 Water-soluble conjugates of phenytoin |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | US20040192928 Reduce skin sensitivity; dissolving 4,5-diphenylimidazole in aprotic solvent; mixing with base and alkyl halide; heating |
| 09/30/2004 | US20040192922 Novel azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments |
| 09/30/2004 | US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents |
| 09/30/2004 | US20040192750 Antiproliferative agents; anticancer agents; neurodegenerative agents sexual disorders; antidiabetic agents; urogenital disorders; antidiabetic agents; obesity; muscular disorders; aftertreatment surgery; autoimmune disease |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |
| 09/30/2004 | US20040192719 Peptide deformylase inhibitors |
| 09/30/2004 | US20040192676 Ligands of melanocortin receptors and compositions and methods related thereto |
| 09/30/2004 | US20040187225 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye |
| 09/30/2004 | CA2519475A1 Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | CA2518852A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | CA2518830A1 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | CA2518707A1 Compounds, a process for their preparation and their use as dyes and pigments |
| 09/29/2004 | EP1462445A1 Paraphenyldiamine derivatives concisting of a cyclic diaza group substituted by a cationic radical and use of these derivatives for dyeing keratin fibres |
| 09/29/2004 | EP1462444A1 Intermediate for biotin and process for producing the same |
| 09/29/2004 | EP1461345A2 Copper deposition using copper formate complexes |
| 09/29/2004 | EP1461332A2 Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids |
| 09/29/2004 | EP1461320A2 Enantioselective transformation of alfa,beta-unsaturated ketones using chiral organic catalysts |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461034A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 09/29/2004 | EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/29/2004 | EP1064267B1 Novel cationic coupling agents, their use for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods |
| 09/29/2004 | EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 09/29/2004 | EP0928289B1 Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1532195A Novel method for preparing olmesartan |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168707C 4-guanidinobenzamides antifertility compounds |
| 09/29/2004 | CN1168441C Use of dexmedetomidine for ICU sedation |
| 09/28/2004 | US6797828 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof |
| 09/28/2004 | US6797827 Process for the preparation of alpha-amino acids by hydrolysis of hydantoins at elevated pressure and elevated temperature |
| 09/28/2004 | US6797824 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 09/28/2004 | US6797805 Organic polymers and novel polymerizable compounds |
| 09/28/2004 | US6797723 Heterocycle substituted diphenyl leukotriene antagonists |
| 09/28/2004 | US6797717 Acyl coenzyme a cholesterol acyltransferase (acat) inhibitors |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/23/2004 | WO2004081643A1 Lenslet array with polarization conversion |
| 09/23/2004 | WO2004080984A1 Insecticidal phthalamide derivatives |
| 09/23/2004 | WO2004080974A1 A purification method of ionic liquids to obtain their high purity |
| 09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004064723A3 Inhibitors and methods of use thereof |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2004014973A3 Biodegradable polymer |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186151 E.g., 2-[3-(4'-Methoxyphenyl)-propionylamino]-2-(4'-n-butoxy-3'-carboxyphenyl)-2-ethyl[4-(4'-nitrophenyl)]imidazole; inhibitors of protein tyrosine phosphatases; antidiabetic, -carcinogenic, -inflammation agents; antiallergens; infections; modulation of growth hormones/factors; Alzeimer's; obesity |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186060 [1-(3-cyano-benzyl)-1-([[(5-cyano-thiophen-2-ylmethyl)-carbamoyl]-methyl]-carbamoyl)-3-methanesulfonyl-propyl]-carbamic acid methyl ester; trypsin-like serine protease; for treatment of tumors and metastasis cancer |
| 09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/22/2004 | EP1460478A1 Dry film photoresist |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458686A1 Benzocyclodecane derivatives with antitumor activity |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458380A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1223916B1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | CN1531540A Heterocyclic compounds and cerebral function improvers containing same as active |
| 09/22/2004 | CN1531531A Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 09/22/2004 | CN1530106A Medicine composition for treating diabet mellitus |
| 09/22/2004 | CN1530105A Medicine composition for treating diabets and mellitus |
| 09/22/2004 | CN1168099C Ionic liquids as solvents |
| 09/22/2004 | CN1167467C Antiswelling medicine |